Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia

類似資料

• Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy
  著者:: Yamashita, Fumie, 等
  出版事項: (2013)
• Predictive factors in patients with EGFR mutation-negative non-small cell lung cancer treated with erlotinib
  著者:: ISHII, HIDENOBU, 等
  出版事項: (2014)
• Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy
  著者:: Ishii, Hidenobu, 等
  出版事項: (2017)
• Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib
  著者:: Azuma, Koichi, 等
  出版事項: (2014)
• Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
  著者:: Matsuo, Norikazu, 等
  出版事項: (2016)